Scranton Hematology Oncology — Scranton, Pennsylvania

Scranton Hematology Oncology is a clinical research site located in Scranton, Pennsylvania, United States 18510.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Scranton Hematology Oncology has participated in 44 clinical trials with 9 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, NSABP Foundation Inc, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Scranton

Browse all research sites in Pennsylvania · View every site in Scranton

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Scranton Hematology Oncology?

Scranton Hematology Oncology has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Scranton Hematology Oncology conducted?

Scranton Hematology Oncology has 44 clinical trials on record, with 9 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Scranton Hematology Oncology accredited by Crixeo Clinical Trials?

Scranton Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Scranton Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.